Skip to main content
Daniel Chancellor on Muck Rack

Daniel Chancellor

As seen in: Bandcamp Daily, Pharmaphorum, Informa Connect, Citeline, In Vivo, Scrip, Clinical Leader, Life Science Leader, PM360, The Medicine Maker and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Daniel

Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

European biopharma at a crossroads

|
By Daniel Chancellor
| Pharmaphorum Verified
Europe’s position in the global biopharma ecosystem is undergoing a period of fundamental change. Once a steady pillar of pharmaceutical R&D and early innovation, the region now finds itself squeezed between the investment dominance of the United States and the highly efficient and fast-growing China. This is not a short-term dip or market correction.
Open in Who Shared Issue with article?

Too Big To Refill? Pharma’s Race To Replace $300bn In Expiring Revenues

|
By Daniel Chancellor
| Citeline Verified
An extensive list of blockbuster drugs face patent expiry over the next six years, putting significant revenues at risk for major companies. While Eli Lilly and Novo Nordisk are reaping the rewards of GLP-1 successes, other large pharmas face steep challenges in closing their growth gaps. (Nasirkhan/Shutterstock) Key Takeaways A wave of patent expirations will expose blockbuster drugs to generic and biosimilar competition. Too Big To Refill?
Open in Who Shared View Duplicates (2) Issue with article?

Sino Biopharmaceutical Limited

|
By Dexter Yan Verified, Daniel Chancellor, Elizabeth Cairns Verified
| Citeline Verified
https://www.sinobiopharm.com/ Industry Pharmaceuticals Generic Drugs Drug Delivery Nutraceuticals Specialty Pharmaceuticals Vaccines Biotechnology Drug Discovery Technologies Molecular Diversity Natural Products Other Names/Subsidiaries Beijing Tide Pharmaceutical Co Ltd, invoX Pharma Jiangsu Chia Tai Tianqing Pharmaceutical Co Ltd, Jiangsu Chia Tai Fenghai Pharmaceutical Co Ltd, Qingdao Chia Tai Haier Pharmaceutical Co Ltd, Jiangsu Chia Tai Qing Jiang Pharmaceutical Co Ltd, etc.
Open in Who Shared Issue with article?
See all 56 articles